Risk factor
High price volatility
Profitability factor
Very low or no dividends
About
Hinge Health, Inc. develops health care software for joint and muscle health. The company designs its platform to address a musculoskeletal care, acute injury, chronic pain, and post-surgical rehabilitation. It also provides various administrative and operations support services. The company was founded in 2012 and is headquartered in San Francisco, California.
Company Valuation
Based on key historical and expected multiples, the stock is overvalued relative to its peers. In particular, the stock is overpriced on P/E, overvalued on P/FC.
Target Price
The average target price of HNGE is 68 and suggests 29% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to increase